Item 8.01 Other Events.

On January 19, 2023, Synlogic, Inc. (the "Company") issued a press release announcing that SYNB1934 was granted Rare Pediatric Disease Designation by the U.S. Food and Drug Administration for the potential treatment of phenylketonuria. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits

Exhibit
  No.       Description

99.1          Press Release dated January 19, 2023.

104         Cover Page Interactive Data File (embedded within the Inline XBRL
            document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses